Company
United StatesPublic company, NASDAQ: SRPTSarepta Therapeutics, Inc. (NASDAQ: SRPT), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Sarepta Therapeutics, Inc. in Cambridge, Massachusetts. 3 FDA inspections on record, 1 Form 483, last inspected December 06, 2021. Publicly traded as NASDAQ: SRPT.
Company Profile
This profile covers Sarepta Therapeutics, Inc. based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected April 12, 2018. Last inspected December 6, 2021.
Most cited issue areas
- Periodic safety report missing ICSR1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1159812 |
| April 18, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1091489 |
| April 12, 2018 | VAI | Human Drugs · Bioresearch Monitoring | 1048077 |
FDA documents
Other FDA documents (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Sarepta Therapeutics, Inc.
Stock ticker
SRPT
Exchange
NASDAQ
Share price
$16.01
Market cap
$1.7B
Price as of
November 13, 2026
FEI Number
3011431238
Address
215 1st St, Cambridge, Massachusetts 02142, United States
Country
United States
ID: e8742d5e-ca73-4f13-bc9f-d8b4a7b0875e